Glenmede Trust’s Abiomed Inc ABMD Stock Holding History

Glenmede Trust’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,150	Closed	-$281K	–	1360
2022 Q3	$281K	Buy	1,150 +88	+8%	+$23.8K	﹤0.01%	986
2022 Q2	$262K	Buy	1,062 +72	+7%	+$19.4K	﹤0.01%	1034
2022 Q1	$327K	Sell	990 -13	-1%	-$4K	﹤0.01%	1013
2021 Q4	$359K	Sell	1,003 -239	-19%	-$80.7K	﹤0.01%	1003
2021 Q3	$403K	Buy	1,242 +30	+2%	+$10.2K	﹤0.01%	957
2021 Q2	$377K	Sell	1,212 -158	-12%	-$48.5K	﹤0.01%	963
2021 Q1	$436K	Sell	1,370 -1	-0.1%	-$320	﹤0.01%	885
2020 Q4	$444K	Sell	1,371 -188	-12%	-$52K	﹤0.01%	867
2020 Q3	$430K	Sell	1,559 -559	-26%	-$161K	﹤0.01%	829
2020 Q2	$511K	Sell	2,118 -393	-16%	-$78.9K	﹤0.01%	761
2020 Q1	$427K	Hold	2,511	–	–	﹤0.01%	950
2019 Q4	$427K	Sell	2,511 -34	-1%	-$6.3K	﹤0.01%	950
2019 Q3	$452	Buy	2,545 +5	+0.2%	+$1.08K	﹤0.01%	918
2019 Q2	$660	Buy	2,540 +32	+1%	+$8.49K	﹤0.01%	839
2019 Q1	$715	Sell	2,508 -12	-0.5%	-$3.99K	﹤0.01%	808
2018 Q4	$818	Sell	2,520 -164	-6%	-$57K	﹤0.01%	759
2018 Q3	$1.21M	Sell	2,684 -262	-9%	-$103K	﹤0.01%	711
2018 Q2	$1.21M	Buy	2,946 +165	+6%	+$59.8K	0.01%	675
2018 Q1	$520K	Hold	2,781	–	–	﹤0.01%	915
2017 Q4	$520K	Sell	2,781 -246	-8%	-$45.9K	﹤0.01%	915
2017 Q3	$509K	Sell	3,027 -1,588	-34%	-$240K	﹤0.01%	900
2017 Q2	$577K	Hold	4,615	–	–	﹤0.01%	907
2017 Q1	$577K	Buy	4,615 +1,022	+28%	+$118K	﹤0.01%	907
2016 Q4	$404K	Buy	3,593 +23	+0.6%	+$2.66K	﹤0.01%	1000
2016 Q3	$458K	Hold	3,570	–	–	﹤0.01%	954
2016 Q2	$389K	Sell	3,570 -167	-4%	-$16.6K	﹤0.01%	1000
2016 Q1	$353K	Buy	3,737 +48	+1%	+$4.05K	﹤0.01%	1008
2015 Q4	$332K	Sell	3,689 -454	-11%	-$38.5K	﹤0.01%	1047
2015 Q3	$383K	Buy	4,143 +60	+1%	+$5.29K	﹤0.01%	1004
2015 Q2	$267K	Buy	4,083 +83	+2%	+$5.51K	﹤0.01%	1140
2015 Q1	$286K	Hold	4,000	–	–	﹤0.01%	1148
2014 Q4	$152K	Sell	4,000 -15,151	-79%	-$478K	﹤0.01%	1404
2014 Q3	$475K	Sell	19,151 -7,310	-28%	-$185K	﹤0.01%	889
2014 Q2	$664K	Hold	26,461	–	–	0.01%	793
2014 Q1	$688K	Hold	26,461	–	–	0.01%	787
2013 Q4	$706K	Hold	26,461	–	–	0.01%	764
2013 Q3	$504K	Hold	26,461	–	–	0.01%	818
2013 Q2	$570K	Buy	+26,461	New	+$532K	0.01%	748

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Glenmede Trust's ABMD Position: Q4 2022 in Review

Glenmede Trust sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,150 shares — an estimated $281K sold.

Glenmede Trust first reported a position in ABMD in Q2 2013 and held it in 38 quarters. The position peaked at $1.21M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Glenmede Trust reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Glenmede Trust sold 1,150 Abiomed Inc shares in Q4 2022, an estimated $281K.
Glenmede Trust first reported a position in Abiomed Inc in Q2 2013 and held it in 38 quarters.
Glenmede Trust's Abiomed Inc position peaked at $1.21M in Q3 2018.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Glenmede Trust's 13F filing for Q4 2022, filed 14 Feb 2023.